C9053 Injection, crizanlizumab-tmca, 1 mg

Short descriptor: Inj, crizanlizumab-tmca

⚠ Terminated HCPCS Level II 2026
Terminated Code
C9053 was terminated as of 2020-06-30 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open C9053 in the app →

Look up C9053 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

C9053 is the HCPCS Level II code for Injection, crizanlizumab-tmca, 1 mg (2026). It belongs to Section C — Outpatient PPS (Hospital). Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Statute.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Statute (indicator 53)
Type of Service
Other medical items or services
Effective Date
2020-07-01
Termination Date
2020-06-30
2026 Maintenance
No change this year

References

Cite This Page

Reference C9053 with the canonical source and edition:

C9053 — Injection, crizanlizumab-tmca, 1 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/C9053

Canonical URL: https://icd10codingpro.com/hcpcs-codes/C9053

Related Codes in Section C

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial